Chapter 29: Sulfonamides & Nitroimidazole Antibiotics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Usually we are here picking apart the latest tech trends, diving into some obscure corner of history, or, you know, trying to figure out the geopolitical landscape.

But today, today we are pivoting hard.

We are entering the last minute lecture zone.

That's right.

We know who you are.

We see you out there.

You are surrounded by highlighters, empty coffee cups, and a stack of textbooks that probably way more than a small car.

You're a nursing student, or maybe a med student, or maybe just someone who really, really wants to understand how drugs work.

And you are staring down the barrel of a big exam.

And we are here to help.

Specifically, we are looking at Chapter 29 from Pharmacology, a patient -centered nursing process approach, the 12th edition.

The topic on this lab today is sulfonamides and nitromidazoles.

Now, if you are just a casual listener, those words might sound like, I don't know, something you'd use to clean a swimming pool.

Right.

But if you are in healthcare, these are absolutely foundational weapons in your arsenal.

They really are.

And look, we get it.

Looking at a pharmacology textbook can be intimidating.

It's dense.

It's chemical.

It's full of charts that make your eyes cross.

Our mission today is to take the panic out of the process.

We are going to go through this chapter exactly as it is laid out.

We aren't going to skip the hard stuff.

Nope.

We are going to break down the mechanisms, the drug classes, the side effects.

And this is the big one, the nursing implications.

Right.

Because it's not just about memorizing a chemical formula or a generic name.

It's about keeping the patient safe.

It's about clinical judgment.

That's the whole game.

So I'm going to be playing the role of the student here.

I've got the book open.

I'm looking at these diagrams and I'm going to ask the questions that might feel a little, well, a little basic.

And I'll say it right now.

There are no basic questions in pharmacology.

If you don't understand the foundation, you can't possibly make the right clinical decisions when the pressure is on.

I'm here to guide us through the text and help connect those docs.

So we can ace the exam.

And more importantly, so you can be a safe, competent nurse.

Love it.

Okay.

Let's dive in.

The origin story.

Section one starts with sulfonamides.

And immediately I'm seeing a date that surprises me.

1935.

1935.

Yes.

That is a crucial bit of context.

It feels ancient in medical terms, doesn't it?

It really does.

I mean, my grandparents weren't even born then.

That's a long time ago.

Exactly.

But here is the thing.

Sulfonamides were actually the first group of drugs used against bacteria.

This was before the quote unquote golden age of antibiotics really took off.

Wait, I thought penicillin was the first, you know, the whole Alexander Fleming mold in the Petri dish store.

A classic misconception.

Penicillin was discovered earlier.

That's true in 1928, but it wasn't widely used or mass produced until the 1940s, really for World War II.

Sulfonamides were the first systemic antibacterial treatment available on a large scale.

So if you got a bad infection in say 1936, you were getting a sulfur drug.

That was the best they had.

The text mentioned something really interesting about where they came from.

It says they were isolated from a coal tar derivative, coal car, like the sludge they used to seal driveways or patch roofs.

The very same.

It sounds horrifying, but in the early 20th century,

the chemical dye industry, especially in Germany, was just booming.

Scientists realized that certain dyes had antimicrobial properties.

So they were trying to dye fabric and accidentally found a way to kill bacteria.

Something like that.

They refine that coal tar derivative and eventually they isolated the active component.

And that brings up a really important distinction the text makes right away.

What's that?

Technically, sulfonamides are not antibiotics in the strictest biological definition of the word.

Hold on, we are studying antibiotics.

This is the antibiotic unit.

How can they not be antibiotics?

I know, it's confusing.

We use the term generally in the therapeutic sense, but biologically speaking, a true antibiotic is a substance produced by a microorganism, like a mold or a fungus that kills other bugs.

Okay, so penicillin comes from the penicillin mold.

It's natural chemical warfare.

Exactly.

Sulfonamides, they're purely synthetic.

They're made in a lab from chemicals.

So the text is very precise in referring to them as antibacterials.

Okay, that is a subtle, but really important distinction.

If I see a multiple choice question asking which drug is synthetic versus natural,

sulfonamide is my synthetic answer.

Got it.

So they were the Kings of the Hill in 1935.

What happened?

Why did they fall out of favor?

Well, penicillin arrived, and when penicillin hit the market in the 40s, it was seen as a true miracle drug.

It was incredibly effective and at the time had a very safe profile.

The use of sulfonamides just adipped significantly because penicillin was easier and often more potent.

But they didn't disappear.

No, they didn't.

The text says they made a comeback, and they did for two main reasons.

One, bacteria are smart.

They started developing resistance to penicillin almost immediately, so we needed alternatives.

And the second reason?

We got better chemistry.

We developed newer, better versions of sulfonamides that weren't as harsh, and crucially, we started combining them with other drugs.

Ah, the combination therapies.

Exactly.

You'll hear us talk a lot about TMP -SMZ later on.

That is the heavy hitter today.

Got it.

So they aren't obsolete antiques.

They are vintage classics that have been remastered.

That's a way to put it.

Okay, so let's talk about how they work.

The mechanism of action.

The text uses the word bacteriostatic.

Can we unpack that?

Absolutely.

This is concept number one for your exam.

There are two main ways to handle a bacterial invasion.

You can nuke them.

That's bactericidal.

Cidal means death.

It kills the bacteria outright.

Or you can just stop them from reproducing.

That's bacteriostatic.

Sulfonamides are generally bacteriostatic.

They inhibit the growth of the bacteria.

They press the pause button on the bacteria's ability to divide and multiply.

So they basically stop the army from growing, and then the body's own immune system comes in and cleans up the mess.

You've got it.

You're holding the enemy in place so your white blood cells can come in and finish the job.

And the way they do this is, well, it's really fascinating.

It is all about folic acid.

Folic acid.

That's the stuff in prenatal vitamins, right, to prevent birth defects.

It is.

And here's the biology lesson.

Bacteria, just like our cells, need folic acid.

They need it to synthesize RNA, DNA, and proteins.

If you can't make DNA, you can't divide.

If you can't make proteins, you can't function.

So without folic acid, the bacterial cell just hits a wall.

It can't build anything.

Exactly.

It's like a construction site running out of concrete.

Everything grinds to a halt.

Okay.

But here's the big question.

If the drug stops folic acid synthesis, why doesn't it hurt us?

We need folic acid, too.

Ah, that is the million dollar question.

This is the concept of selective toxicity,

and it relies on a fundamental difference between humans and bacteria.

Okay.

Humans are, well, we are kind of lazy.

We do not synthesize our own folic acid.

We can't make it from scratch.

We have to eat it.

We get it from our diet leafy greens, fortified cereals, supplements.

Correct.

We are folate consumers.

Yeah.

Bacteria, on the other hand, are folate producers.

Most bacteria cannot absorb folic acid from the environment.

They are like little chefs.

They have to cook up their own folic acid inside the cell using raw materials.

So the drug walks into the bacterial kitchen and, what, steals the stove.

That is a great analogy.

Sulfonamides act as a chemical imposter.

They look almost identical to a molecule called piva -paraminobinzoic acid.

PAA.

I've seen that in old sunscreens.

You have.

Pebe is one of the key ingredients bacteria use to make folate.

The bacterial enzyme that is supposed to grab pava and start the recipe, it grabs the sulfonamide instead because it looks so similar.

And then the whole process jams up.

It tries to build with the fake ingredient, and the assembly line stops.

It is like putting a fake key in a lock and snapping it off.

The lock is jammed.

The door will not open, and the bacteria essentially starve.

Precisely.

And because our human cells do not have that lock, we do not have the machinery to synthesize folate from pava.

The drug just floats right past our cells.

Ideally, it hurts them and does not touch us.

Ideally.

We will get to the side effects later where that toxicity is not quite so selective.

But first, where do we use these drugs today?

The text mentions resistance is an issue.

Resistance is always an issue with antibiotics.

But sulfonamides are still the go -to for a few specific things.

The biggest one is urinary tract infections, or UTIs.

Why UTIs specifically?

Two reasons.

First, they concentrate really well in the urine, so you get a high dose of the drug right where the infection is.

And second, they are highly effective against E.

coli.

Which is the main culprit in UTIs.

Ah, whelmingly.

The text notes they are approximately 90 % effective against E.

coli, which is the leading cause of UTIs.

That's a really solid number.

90%.

It is.

They are also used for ear infections, otitis media, and occasionally for newborn eye

You'll also see them used for Meningococcal meningitis, and against some other specific nasties like Chlamydia and Toxoplasma gondii.

Toxoplasma?

Isn't that the parasite associated with cat litter?

That's the one.

It can be very dangerous for pregnant women and immunocompromised people.

Sulfonamides are a key treatment there.

Okay, but the text puts a big warning label here.

Sulfonamides are not effective against viruses or fungi.

Critical point.

Antibacterials kill bacteria.

Do not take them for the flu.

Do not take them for a viral cold.

It won't help, and it just contributes to the larger problem of resistance.

Okay, moving on to section two.

Pharmacokinetics and dynamics.

This is usually the dry part of the chapter.

How it absorbs, how it excretes, but I feel like there is a very specific physical danger hidden here.

There is.

You're right.

Let's look at pharmacokinetics.

How the drug moves through the body.

The text says they are well absorbed by the GI tract.

So you can take them as pills.

That's convenient.

Very.

And they distribute widely to body tissues and even cross the blood -brain barrier, which is why they work for meningitis.

And then the liver metabolizes them and the kidneys excrete them.

Standard stuff.

Correct.

But that kidney excretion part is where things get tricky and where your nursing skills become critical.

This is the crystallization problem that the outline mentions.

That sounds painful.

It can be agonizing.

This brings us to a key physical property of sulfonamides, especially the older ones like sulfateazine.

They are poorly soluble in urine.

Poorly soluble.

So they don't dissolve well, like sand and water.

Exactly.

Imagine trying to dissolve too much sugar in cold iced tea.

It just sits at the bottom in a gritty pile.

In the kidneys, if the urine is acidic and there isn't enough fluid volume, the drug precipitates out of the solution and forms crystals.

You get crystalluria.

Basically tiny shards of drug crystals forming in the renal tubules.

Oh, wow.

It's like having microscopic broken glass inside the delicate filtration units of your kidneys.

This can cause severe pain, obstruction,

and significant kidney damage.

So as a nurse, this is a huge red flag.

When the tech says fluid intake is a critical nursing consideration, they aren't just suggesting you stay hydrated for general wellness.

No.

They're saying you must prevent your patient's kidneys from turning into a rock tumbler.

That's it.

Exactly.

The text does emphasize that newer sulfonamides are more water soluble, so the risk is lower than it was back in 1935, but it is not zero.

Fluid intake is the critical nursing consideration here.

You have to flush those kidneys.

We'll get to the specific numbers on that later.

I think the text says 2000LL, but I'm mentally underlining drink water in massive letters right now.

Good.

Now, regarding pharmacodynamics, the text categorizes them by duration.

Short acting versus intermediate acting.

And it mentions sulfatazine specifically as short acting.

Yes.

Sulfatazine has rapid absorption and rapid excretion.

The text highlights a very specific use for it.

Prophylactic treatment of rheumatic fever.

Rheumatic fever?

I honestly thought that was a history book disease, like something from a Victorian novel.

It is rare in developed countries now, thankfully, but it absolutely still happens.

It's a serious complication of untreated streptococcal infections, strep throat, that can lead to permanent heart valve damage.

And you'd normally use penicillin for that, right?

Normally, yes.

But what if the patient is allergic to penicillin?

You need a backup.

And that's sulfatazine.

Precisely.

It's the alternative choice.

But again, because it's an older drug and because it is short acting and less soluble, that crystallization risk is higher.

More vigilance is needed.

Okay, that makes sense.

Let's talk about when things go wrong.

Section three, side effects and adverse reactions.

I'm seeing a list here that ranges from, you know, annoying to downright scary.

It is a spectrum for sure.

Yeah.

The most common side effect is an allergic response, a skin rash, some itching.

Is that a stop the drug situation or just take some Benadryl?

Usually you stop the drug and report it.

Because while anaphylaxis, the throat closing, can't breathe reaction is uncommon, it is possible.

A simple rash could be the first sign.

Okay, but let's look at the blood disorders.

This is what's really catching my eye.

Yes, this is serious stuff.

Hemolytic anemia, aplastic anemia, low WBCs, low platelets.

And the text notes, this usually happens with prolonged use or high dosages.

Yeah.

Let's break those terms down.

Hemolytic anemia means the drug is causing the red blood cells to literally burst.

They're being destroyed faster than the body can make them.

Okay, so the patient would be pale, tired, short of breath.

Exactly.

And aplastic anemia, that's even worse.

What's that?

That means the bone marrow, the factory, for all of our blood cells has gone on strike.

It just stops making red cells, white cells, and platelets.

It's a total shutdown.

And low WBCs, white blood cells, means the patient can't fight off other infections.

That's a granulocytosis.

Correct.

And low platelets, thrombocytopenia, means you can't clot your blood.

So clinically, as a nurse, I'm not just looking for a rash.

I'm asking my patient about unusual fatigue.

Yes.

Or if they're bruising really easily, or if they have a sore throat that won't go away, which could be a sign of low white blood cells.

Those are the key assessment points.

If a patient on long -term sulfonamides calls you and says, I'm bruising really easily, or my gums are bleeding when I brush my teeth, you need to get them in for labs immediately.

Wow.

Okay.

The text also mentions GI issues.

Anorexia, nausea, vomiting.

That seems pretty standard for most antibiotics.

It is.

A lot of drugs are tough on the stomach.

But let's go back to the kidneys for a second.

We mentioned crystalluria, but the text also mentions hematuria.

Blood in the urine.

Right.

If those tiny crystals are scraping up the lining of the urinary tract, you're going to see blood.

It's a direct sign of that kidney irritation we were talking about.

Okay.

Here's a weird one.

Photosensitivity.

The text defines it as an excessive reaction to direct sunlight or UV light.

This is a classic board exam question.

Patients taking sulfonamides burn very, very easily.

So this isn't just wear a hat and some SPF 15.

This is avoid the sun.

This is avoid sunbathing, avoid tanning beds, avoid prolonged exposure to any UV light.

You have to explicitly tell the patient this.

They might go out for a nice walk, thinking they're fine, or just sit by a window on a sunny day and come back with a severe blistering burn.

It actually alters the skin's reaction to UV radiation.

That's right.

Okay.

And then there's cross -sensitivity.

The text says an allergy to one sulfonamide leads to sensitivity to another.

That seems logical.

It is, but it goes further than that.

So, phonemides have a specific chemical structure.

And not just in these antibiotics, other drugs share that same basic structure.

Like what?

Specifically, some sulfonylureas, which are oral medications for type 2 diabetes, and thiazide diuretics, which are common blood pressure water pills.

So if a patient's chart says allergic to hydrochlorothiazide or had a reaction to glipicide, I should be extremely wary of giving them a sulfa antibiotic.

You should be very, very wary.

The immune system is essentially pattern matching.

It sees that chemical structure, remembers the bad reaction it had to the diuretic, and attacks the antibiotic with the same ferocity.

That's a huge safety check.

And finally, pregnancy.

The text says avoid in big letters.

Yes.

Avoid during pregnancy.

It can cause congenital malformations and neural tube defects.

But specifically in the last trimester, the third trimester, there's a massive risk of something called connectoris.

Connectoris.

That sounds intense.

What is it?

It is devastating.

It's a form of brain damage in newborns caused by excessively high levels of bilirubin in the blood.

How does the drug cause it?

It's a displacement issue.

In the blood, bilirubin usually travels around attached to a protein called albumin, like a passenger in a taxi.

Sulfonamides are bullies.

They're more attracted to that albumin, so they knock the bilirubin out of the taxi and take its seat.

So now you have all this free -floating bilirubin.

Exactly.

And in a fetus or newborn, the blood -brain barrier isn't fully developed.

That free bilirubin crosses into the brain and deposits in the neural tissue.

It's toxic to the brain cells and causes permanent neurological damage.

Okay, so big bold letters, no pregnancy,

and absolutely not in the third trimester.

That's the takeaway.

Alright, let's meet the star of the show, section four, the power couple, trimethoprim,

sulfamethoxazole, or as the cool kids call it, TMP -SMZ.

Or Ceptra, or Bactrim, has a lot of brand names.

This is the most common sulfonamide formulation you will see in practice.

By far.

It's a combination drug.

What's the recipe?

It contains one part trimethoprim, which is TMP, and five parts sulfamethoxazole, which is SMZ, so a one to five ratio.

Why combine them?

Why not just give more of the sulfur stuff?

One word, synergism.

That's the key word for your exam.

Synergism.

The whole is greater than the sum of its parts.

One plus one equals three.

In this case, one plus one equals dead bacteria.

Remember how we said sulfonamide stopped the first step of folic acid synthesis?

They mimic that PAY -B molecule.

Right, the fake key in the lock.

Well, trimethoprim is not a sulfonamide.

It's a different antibacterial.

But it also interferes with folic acid synthesis.

It just hits a different step in the same process.

It inhibits an enzyme further down the line called dihydrofolate reductase.

So, sulfomethoxazole trips the bacteria at the front door, and if they manage to stumble past that, the trimethoprim hits them with a baseball bat in the hallway.

That is a violent but remarkably accurate analogy.

By blocking two sequential steps in the same essential metabolic pathway, the result is much more powerful.

So powerful that it changes the drug's effect.

Exactly.

While each drug alone is bacteriostatic,

just pausing growth, together they become bactericidal.

They kill the bacteria.

That's a huge upgrade.

It is.

And it has another critical benefit, resistance.

Bacterias are smart.

They can figure out how to bypass one blockade.

They can mutate away around the epimimicry.

But bypassing two different blockades at the exact same time is statistically much, much harder.

So using them together slows down the development of bacterial resistance.

Significantly.

That makes a lot of sense.

So what do we use this dynamic duo for?

It is a workhorse.

UTIs are number one, of course.

But also intestinal infections like shigellosis, lower respiratory tract infections like bronchitis, otitis media, prostatitis, even gonorrhea.

The text also specifically mentions AIDS patients.

Yes, this is a very specific and critical indication.

TMP -SMZ is used to prevent newocystis criniae pneumonia, which you'll often see shortened PCP.

And that's an opportunistic infection.

It's an opportunistic fungal infection that acts a lot like a bacteria.

Back in the early days of the AIDS epidemic, before we had effective antiretroviral therapy, this was often the illness that killed patients.

Their immune systems were too weak to fight it off.

So TMP -SMZ is used not just to treat it, but as prophylaxis, as prevention in patients with low T cell counts to keep them safe.

Exactly.

It's a lifesaver in that population.

And pharmacokinetically, how does TMP -SMZ behave?

The half -life is conducive to twice -daily dosing or BID, which is great for patient compliance.

And like the other sulfonamides, it's excreted as unchanged metabolites in the urine.

Which means?

Which means the fluid intake rule still applies.

You still have to worry about crystals.

Just because it's a modern combo drug doesn't mean you can skip the water.

The danger is still there.

Okay, let's get into the weeds.

Section 5, the TMP -SMZ prototype drug chart breakdown.

This is where the text lists all the interactions.

And looking at this list, TMP -SMZ really does not play well with others.

It does not.

And this is where a good nurse catches errors that save lives.

A doctor is often focused on the infection and might sometimes miss the interaction with the patient's chronic meds.

Let's look at the drug interactions column.

First up, sulfonylureas.

We mentioned these earlier, the diabetes meds like glipizide or gliboride.

Oral hypoglycemic agents, yes.

TMP -SMZ increases the hypoglycemic response.

How does that happen?

Is it another displacement thing?

It is.

Displacement again.

Both drugs want to ride on that albumin protein in the blood.

TMP -SMZ is aggressive.

It kicks the diabetes drug off the protein.

And free drug is active drug.

Right.

So suddenly the patient has way more active diabetes medication floating around in their system than their body is used to.

So if a diabetic patient takes their normal dose of glipizide and then adds TMP -SMZ for a UTI, their blood sugar could crash.

Dangerously low.

Hypoglycemia.

You need to monitor their blood sugar very closely and the doctor might need to temporarily adjust their diabetes med dose.

Okay, next one.

Warfarin, the anticoagulant.

This feels like a classic danger zone for interactions.

This is one of the most classic interactions in pharmacology.

Warfarin, or coumadin, is a blood thinner with a very narrow safety margin.

Too little, you clot.

Too much, you bleed.

And TMP -SMZ?

It inhibits the liver enzymes that metabolize warfarin and it displaces it from those protein binding sites.

So it's a double whammy.

It stops the body from clearing it out and it makes more of it active at the same time.

It dramatically increases the anticoagulant activity.

Yeah.

If your patient is on warfarin and the doctor prescribes TMP -SMZ, you need to be on high alert.

Their INR, the lab value we watch for clotting time, will skyrocket.

They could start bleeding internally.

Yikes.

Okay, next group.

ACE inhibitors and spironolactone.

These are blood pressure and heart failure meds.

Right.

And these drugs have an effect on how the kidney handles potassium.

They make the body hold onto it.

And let me guess, TMP -SMZ does too.

It does.

It also decreases potassium excretion.

So if you combine them, you risk hyperkalemia, dangerously high potassium levels in the blood.

Which is very bad for the heart.

It can cause life -threatening arrhythmias.

Your heart relies on a very precise potassium balance to conduct its electrical signals.

You mess with that, you get palpitations or worse.

And finally, the chart lists phenytoin and methotrexate.

Phenytoin is for seizures.

Methotrexate is for cancer or autoimmune diseases like rheumatoid arthritis.

TMP -SMZ increases the toxicity of both.

Phenytoin toxicity, for example, can look like drunkenness, slurred speech, stumbling, confusion.

So my mental checklist when I see TMP -SMZ on a medication list should be, scan the rest of the list for diabetes meds, blood thinners, potassium -sparing heart meds, and seizure meds.

That is a fantastic mental checklist, the big four.

Now the adverse reactions list in this chart brings up some really scary words.

We mentioned Stevens -Johnson syndrome earlier.

Can we paint a clearer picture of what that actually looks like for a patient?

Stevens -Johnson syndrome, or SJS.

It is a severe, and I mean severe, hypersensitivity reaction.

It usually starts with nonspecific flu -like symptoms.

Fever, sore throat, fatigue.

Then a painful red or purplish rash spreads and starts to blister.

And then the skin, it literally sheds.

It detaches.

The top layer of the epidermis dies and slews off.

And this isn't just on the outside skin, it happens on the mucous membranes too.

The eyes, mouth, genitals.

Sounds like a burn.

It looks and is treated like a severe burn.

Patients often end up in the burn unit because they have lost their protective skin barrier.

It's a true medical emergency with a high mortality rate.

And toxic epidermal necrolysis, or TENIN.

That's the even more severe version of SJS, where it covers more than 30 % of the body surface area.

The text also mentions Clostridium difficile -associated diarrhea, CDAD, C.

diff.

Yes.

We see this with many broad -spectrum antibiotics.

The drug is very effective, so it kills the good bacteria in the gut, right along with the bad bacteria causing the UTI.

And that leaves an empty apartment complex in your colon.

A perfect analogy.

C.

diff, which is naturally resistant to many drugs, moves in, takes over, and throws a massive toxic party.

Resulting in severe, watery, and very foul -smelling diarrhea.

And potentially life -threatening colitis.

The teaching point here is critical.

If a patient develops diarrhea while on antibiotics, you do not just give them antidiarrheal meds like Imodium to stop it up.

Why not?

That seems counterintuitive.

Because you are trapping the C.

diff toxin inside the bowel, which can lead to a toxic megacolon, you need to get a stool sample and test for the toxin first.

One last thing in this section.

The do -not -confuse safety alert.

So important.

Yes.

So many drug names can look or sound alike.

The text warns not to confuse SEPTRA, which is a brand name for TMP SMZ, with Sectral.

And Sectral is?

Sectral is a Ceputolol, a beta blocker, a heart medication.

Mixing those up would be a disaster.

Imagine giving a patient with a raging infection a massive dose of a beta blocker that tanks their heart rate.

Exactly.

Always check the spelling.

The other pair is sulfadiazine versus sulfasalazine.

Similar names, but very different uses.

Sulfasalazine is mostly used for inflammatory conditions like ulcerative colitis and rheumatoid arthritis, not systemic infections.

Alright.

Okay, let's move away from the pills and look at other ways to deliver these drugs.

Section 6.

Topical and ophthalmic sulfenamides.

Right.

Sometimes we need to put the drugs directly on the site of infection.

For the eyes ophthalmic, the text mentions sulfasetamide sodium.

Yes, it's very common.

Used for ocular infections like conjunctivitis, what everyone calls pink eye, and for more serious things like corneal ulcers.

It's also used as prophylaxis after an eye injury, or if you get a foreign body in your eye, like a piece of metal or dirt.

To prevent an infection from starting?

Exactly.

Yeah.

But there is a massive safety alert here that the text highlights.

Do not use ointment for the eye unless it has ophthalmic printed on the drug label.

This is a never event.

You cannot make this mistake.

Because skin creams have different bases and preservatives that can damage the eye, right?

They can chemically burn the delicate surface of the cornea.

You could blind someone by putting a standard dermatologic cream in their eye.

Always, always, always check the label.

Speaking of dermatologic, we do use sulfasetamide sodium on the skin too.

We do.

As a cream or gel for seborrheic dermatitis and for certain types of acne.

And then there's burn care.

This is heavy stuff.

Maffaned acetate and silver sulfatazine.

If you ever work in a burn unit, these creams are everywhere.

Why are burns so incredibly risky for infection?

Your skin is your armor.

When it's gone away in a second or third degree burn, you are completely open to the world.

And bacteria absolutely love that raw, moist, protein -rich environment.

Sepsis is the leading cause of death in burn victims after the initial trauma.

So these creams are used to prevent that, to create a barrier.

An antimicrobial barrier, yes.

The text notes that these are covered more in Chapter 45, but mentions a key risk here, hypersensitivity.

Even from a cream?

Yes.

Just because it's a topical cream doesn't mean it stays on the skin.

If the burn area is large, the body absorbs a significant amount of the drug systemically.

You can still get the systemic side effects, the crystals, the allergies, the blood dyscrasias from a cream.

You still have to monitor their renal function and their CBC.

Good to know.

Okay, shifting gears.

We are done with sulfonamides.

Let's talk about the other half of the chapter title, nitroimidazoles.

The prototype drug here is metronidazole.

You almost certainly know it by the brand name, Flagel.

Ah, Flagel.

Yes, I've definitely heard of that.

What's its mechanism?

How does it work?

It also gets inside the cell, but its target is different.

It disrupts DNA and protein synthesis in bacterium protozoa.

It basically gets inside the cell, gets activated, and then starts breaking the DNA strands, which causes cell death.

It is bactericidal.

Who is the target?

What's its hit list?

It is a very specific hit list.

It's fantastic against anaerobic bacteria bugs that live without oxygen, like bacteroids and clostridium.

Wait, clostridium?

As in C.

diff?

The very same.

So there's a bit of irony here.

Other antibiotics can cause C.

diff, but metronidazole is one of the main drugs we use to treat C.

diff.

Exactly.

It's often the first -line treatment for mild to moderate cases.

It kills the anaerobic bacteria that are causing the colitis.

What else is on the hit list?

It also targets Helicobacter pylori, the bacteria that causes most peptic ulcers.

And it's very effective against protozoa, like Trichomonas, which is an STI, and Giardia.

Giardia.

That's beaver fever from drinking contaminated stream water.

Oh, that's the one.

Okay.

So administration, the text says oral, parenteral, IV, and topical.

But there's a safety note on the IV.

Yes.

Administer metronidazole slowly, over 30 to 60 minutes.

Why slowly?

What happens if you push it too fast?

It's very irritating to the veins and can cause a rapid drop in blood pressure or hypotension.

This is not a drug you slam in.

It's a slow, steady infusion.

Now the side effects, some of these are memorable.

They are.

The metallic taste.

That is the classic complaint.

Patients will say their mouth tastes like they are sucking on a penny or licking a 9 -volt battery.

It can really kill the appetite.

And dry mouth and tongue and urine discoloration.

Yes.

It can turn the urine dark or reddish brown.

Is that blood?

Should the patient be worried?

No.

And that's a crucial teaching point.

It's not blood.

It's a harmless metabolite of the drug.

But if you don't warn the patient, they will absolutely freak out.

Nurse, I'm peeing soda.

You have to educate them that this is an expected and harmless side effect.

Okay.

Here's the big one.

The warning that should be in flashing neon lights on the bottle?

Alcohol.

This is the disulfiram -like reaction.

It is absolutely non -negotiably critically important.

And disulfiram is that drug they give to people with alcohol use disorder to make them violently ill if they drink, right?

Ant abuse?

Yes.

Metronidazole does the same thing.

It blocks an enzyme in the liver that's responsible for breaking down alcohol.

The result is that a toxic byproduct, acetaldehyde, builds up in the blood.

And what does that feel like?

It feels like you are dying.

Intense flushing of the face, a throbbing headache,

nausea, violent vomiting, shortness of breath, a racing heart.

The text even says circulatory collapse.

It can be.

So we aren't talking about a mild hangover.

We are talking about calling 911.

And this isn't just don't drink a beer with your pill.

No.

This includes cough syrup with alcohol, mouthwash with alcohol, even some cooking wines or desserts that have alcohol in them.

The patient needs to be strictly alcohol -free.

For how long?

Just while they're taking the pills?

Through the entire course of therapy, and this is the party people forget, for at least 48 hours after finishing the last dose.

That 48 -hour window is the gotcha.

People finish the bottle and think, time to celebrate, I'm cured.

And then they are in the ambulance.

You have to be very, very clear about that timeline.

Okay.

That is a critical teaching point.

Are there any other serious adverse effects aside from the alcohol thing?

Seizures and peripheral neuropathy, that's numbness and tingling in the fingers and toes, are rare but possible, especially with high doses or long -term use.

And of course, Stevens -Johnson syndrome is on the list again.

It's a risk with many drugs.

And a quick complimentary therapy alert from the text?

Milk thistle.

Yes.

For patients who take herbal supplements, milk thistle may decrease the absorption of metronidazole, making it less effective.

Okay.

We're cruising.

Section eight, miscellaneous antibacterial drugs.

This is table 29 .3 in the book.

These feel like the special forces drugs, the ones you call in for the really tough situations.

That's a good way to think of them.

They are reserved for specific, usually very serious infections.

First up, chlorophenicol.

The heavy hitter.

The text notes it was discovered way back in 1947.

It's effective against a lot of things, salmonella, typhoid, certain types of meningitis.

It crosses the blood -brain barrier very easily.

But the text says it's only used for serious infections when other drugs fail.

Why the restriction?

Because it is incredibly toxic.

Specifically, it can cause fatal blood disgraces related to bone marrow suppression.

It can cause irreversible aplastic anemia.

It can completely wipe out your bone marrow.

So it's the nuclear option.

You use it only if the patient is going to die from the infection anyway.

Correct.

It's a life or limb risk versus benefit decision made in very dire circumstances.

Next on the table, quinupristin delphophopristin.

That's a mouthful.

It's in the streptogramins class.

This is used for VRE, vancomycin -resistant enterococcus, and for complicated MRSA skin infections.

So the superbugs.

Exactly.

When the standard heavy hitters like vancomycin don't work, we pull this one out.

But there's a big IV issue with it.

Pain, edema, and phlebitis at the injection site.

It hurts.

It's very irritating and damages the veins.

Often these patients will need a central line, catheter in a large vein near the heart, because their smaller personal veins just can't handle the irritation from the drug.

Next up, obiotexaxamab.

Note the MAB ending.

That tells you it's a monoclonal antibody.

This was approved in 2016 specifically for anthrax.

Anthrax, like the bioterrorism agent.

Yes, from the bacteria bacillus anthracis.

This drug works differently.

It doesn't kill the bacteria.

It's an antibody that neutralizes the poison, the toxin that the bacteria makes.

It's for prophylaxis and treatment of inhalational anthrax.

And finally, lefamuline.

A newer class called pleuromutulin.

It's used for community acquired pneumonia.

Side effects.

Injection site reactions and diarrhea are the most common.

We've covered the drugs, now we have to act like nurses.

Section 9, the nursing process.

This is all about clinical judgment.

This is where we put it all together.

The text breaks it down using the nursing process.

Assessment, planning, interventions.

Let's role play this.

You walk into your patient's room.

They've just been prescribed a sulfonamide.

What are you looking for?

Assessment.

Okay, first thing, I'm thinking about the kidneys.

Good.

So you check the urine output.

The text gives a specific number.

Output should be greater than 600 ml all day.

If they are peeing less than that, you hold the drug and call the provider.

You also check their BUN and creatinine labs.

If the kidneys are already failing, we don't give these drugs.

The text says contraindicated in severe renal disease.

Right.

You don't want to add crystals to a failing kidney.

What's next on your assessment list?

Allergies.

The big one.

You have to ask about sulfonamide sensitivity specifically.

And you need to watch their skin.

Look for erythema multiform, that's a full body rash.

Or exfoliative dermatitis peeling skin.

And remember the cross sensitivity.

Right.

So I need to ask, are you allergic to any water pills or diabetes medications?

Perfect.

What else are you checking?

Their medication history.

You're playing detective.

Are they on sulfonylureus?

Are they on warfarin?

Are they on an ACE inhibitor?

You have to look for those interactions we talked about.

And finally, labs.

You need a baseline CBC.

You have to know their white blood cell count and platelet count before you start the therapy so you can see if it drops later.

Okay.

Planning is pretty straightforward.

The goal is the infection resolves.

WBCs stay normal.

Skin stays intact.

Let's jump to interventions.

This is the take action part.

And number one on the list is hydration is key.

The text says administer with a full glass of water.

And here are those specific metrics I was waiting for.

Fluid intake should be at least 2000 mL a day.

That's two liters.

A big soda bottle's worth.

Why that specific number?

To ensure a urine output of at least 1200 mL a day, you need that much volume flowing through the kidneys to keep the drug dilute enough to prevent those crystals from forming.

So drink some water isn't good enough patient teaching.

It's here's a two liter pitcher of water.

Your goal is to finish this by the end of the day.

Exactly.

Be specific and measurable.

What else am I doing?

Monitoring.

You're watching their vital signs.

You want to see their temperature going down.

But you're also watching for subtle signs of bleeding.

A new sore throat, purpura, which is that purple bruising.

That could indicate the blood dyscrasia.

And watching for signs of a super infection.

Stomatitis, which is sores in the mouth, a furry black tongue, or any new genital discharge.

That means the normal flora is gone and something else like yeast or a fungus is moving in.

Okay, last step, patient teaching.

What do we tell them before they go home?

We summarize the key points.

One, drink several quarts of fluid daily, at least 2 ,000 mL.

Two, wear sunglasses and sunblock.

Avoid direct sun because of photosensitivity.

Three, take the meds one hour before or two hours after meals for best absorption and definitely do not take it with antacids.

Correct.

Antacids will decrease the drug's absorption.

And the pregnancy warning again.

Avoid in the last three months especially.

And of course, the number one rule of all antibiotics.

Finish the full course.

Don't stop just because you feel better.

Or the infection will come roaring back and it might be resistant this time.

Okay, we are in the home stretch.

Section 10, case study and review questions.

Time to apply all this.

The text presents a clinical judgment case study.

A 46 -year -old female with a severe urinary tract infection.

She's prescribed trimethoprim sulfamethoxazole TMP SMZ,

160mg, 800mg every six hours.

Okay, first question from the book.

What are the similarities and differences between TMP SMZ and sulfatizine?

We covered this.

Similarity.

Both inhibit folic acid synthesis.

Both carry a risk for crystalluria, although the risk is higher with the older sulfatizine.

And the difference?

The big difference is that TMP SMZ is bactericidal because of that two -step synergistic blockade.

Sulfatizine is only bacteriostatic.

Also, sulfatizine is short -acting while TMP SMZ is intermediate acting but dosed for that constant synergistic effect.

Okay, question two.

Is the dose correct?

168mg every six hours.

Standard dosing is usually every 12 hours, twice a day.

But for a severe infection, every six hours can be used.

The ratio is correct.

One part TMP to five parts SMZ.

That simple 68mg dose is often called double strength or DS.

So yes, for a severe infection, it's a plausible dose.

Question three asks for key patient teaching points.

Okay, let's listen.

Fluid intake should be at least 2 ,000mL a day.

Take it on an empty stomach.

Report any unusual bruising immediately because of the low platelet risk and the potential warfarin interaction.

Right.

Even if she's not on warfarin now, you teach it in case she's prescribed it later.

And about pregnancy?

She's 46, so it's less likely to be an issue, but you always assess and teach it.

Excellent.

Now let's rapid fire the multiple choice review questions from the end of the chapter.

Go for it.

Q1.

A patient is taking sulfasalazine.

What is the most important directive to include in the teaching?

A.

Drink 10 glasses of fluid per day.

B.

Monitor blood glucose carefully.

C.

Avoid driving while taking this drug.

D.

Take this drug with an antacid.

It's gotta be A.

Drink fluids.

10 glasses is roughly 2 ,500mL, which is what we need to prevent crystalluria.

We know antacids are a definite no -no.

Q2.

The nurse is teaching a patient about sulfasalazine.

Which statement will the nurse include?

A.

Avoid all caffeinated beverages.

B.

Administer in 50mL of fluid over 30 minutes.

C.

Avoid sulfonamides during the third trimester of pregnancy.

D.

Use a tanning bed to decrease the rash.

Oh, definitely C.

Avoid in the third trimester to prevent kernicteris.

And D is the exact opposite of the truth.

You have to avoid UV light.

Q3.

A patient is prescribed TMP SMZ.

The nurse should be aware of which possible adverse effect.

A.

Bronchospasm.

B.

Tendon rupture.

C.

Redman syndrome.

D.

Clostridium difficile -associated diarrhea.

It's DC diff is a risk with most broad -spectrum antibiotics, including TMP SMZ.

Quick side note for everyone studying.

Redman syndrome is classic for vancomycin, and tendon rupture is the big warning for fluoroquinolones.

Q4.

Select all that apply.

When teaching a patient about TMP SMZ, the nurse should include which directives.

A.

Report any bruising or bleeding.

B.

Report any diarrhea or bloody stools.

C.

Report any fever, rash, or blisters.

D.

Avoid direct sunlight.

E.

Report increased thirst.

Okay, let's go down the list.

A is yes for bleeding risk.

B is yes for C, diff risk.

C is yes for allergy or SJS risk.

And D is yes for photosensitivity.

E, increased thirst, isn't a specific warning that we do encourage hydration to A, B, C, and D.

Q5, which is a short -acting cell phone in mind.

We talked about this one, sulfatizine.

Boom!

Nailed it.

We got through the whole chapter.

We did.

So let's wrap this up with a quick summary.

What are the big three takeaways you need for the exam?

Okay, here's the cheat sheet.

One, sulfonamides.

Think folic acid inhibition, which makes them bacteriostatic.

Fluids, to prevent crystals.

And allergies, the sulfa allergy, photosensitivity, and SJS.

Two,

TMP SMZ.

Think synergy, which makes it bactericidal.

It's primary use for UTIs and its dangerous drug interactions, especially with warfarin and diabetes meds.

And three.

Three, nitronidazoles.

So, nitronidazole.

Think anaerobes, gut infections, and protozoa.

Remember, it's a key treatment for C.

diff.

And the biggest warning is, end no alcohol because of that desulfurum reaction.

That is a solid, solid cheat sheet.

Before we sign off, here's a provocative thought to leave you with.

We talked about selective toxicity, how these drugs elegantly target a specific pathway, the folic acid synthesis pathway that bacteria use.

But we don't.

It's beautiful, really.

But look at how quickly bacteria adapt.

They find a way around that single roadblock.

So we have to escalate.

We have to build a double roadblock, like with TMP -SMZ.

It's an evolutionary arms race happening in real time inside the patient's body.

Every time we prescribe these drugs, we are making a move on that chessboard.

That's why using them correctly, the right dose for the full course, for the right bug,

is such a profound responsibility, not just a task on a checklist.

Deep.

And a really good reminder of why we study this stuff so intensely.

Exactly.

Well, from the Last Minute Lecture team, thank you for trusting us with your study session.

You've got this.

Go drink a literal quart of water, to prevent crystallaria, obviously.

Stay out of the sun and go ace that exam.

Good luck.

You're going to be great nurses.

See you in the next Deep Dive.